Lozenges For Throat Pain
- Strepsils Strefen Sore Throat Lozenges x 16.
- Strepsils Sugar Free Strawberry Lozenges x 36.
- Strepsils Sore Throat Pain Relief Honey & Lemon Lozenges x 24.
- Strepsils Original Lozenges x 16.
- Strepsils Orange With Vitamin C 100mg Lozenges x 36.
- Strepsils Sore Throat & Cough Lozenges x 24.
Item lainnya
Does Strepsils work for throat pain?
Stand up to your sore throat from the start. Try our best-selling* Strepsils Honey and Lemon lozenges to relieve the discomfort of sore throats. Strepsils provides fast acting relief which helps prevent sore throat pain from getting worse. Not only do Strepsils Honey & Lemon Lozenges soothe your throat, they also help fight bacteria too as they contains two effective antiseptics.
Who should not take Strepsils?
My Account Area – 1. Name of the medicinal product Strepsils Honey and Lemon 2. Qualitative and quantitative composition Amylmetacresol 0.6mg 2,4-Dichlorobenzyl alcohol 1.2mg Excipient(s) with known effect; Glucose (containing Sulphites – Sulphur Dioxide (E220) and Wheat Starch (containing gluten)) Sucrose Invert Sugar (Honey) Fragrance containing allergens – Citral, d-Limonene*, Geraniol and Linalool (present in Terpeneless lemon oil) * present also in Peppermint oil For a full list of excipients, see section 6.1.3. Pharmaceutical form A yellow circular lozenge 4. Clinical particulars 4.1 Therapeutic indications For the symptomatic relief of mouth and throat infections.4.2 Posology and method of administration Posology Use the lowest dose for the shortest duration necessary to relieve symptoms. Adults One lozenge every 2-3 hours up to a maximum of 12 lozenges in 24 hours. Elderly: There is no need for dosage reduction in the elderly. Children over 6 years old: As above for adults. Children under 6 years old: Not suitable for children under 6 years. (see section 4.4). Method of Administration For oral administration. To be dissolved slowly in the mouth.4.3 Contraindications Hypersensitivity to any of the ingredients.4.4 Special warnings and precautions for use Not to be given to children under 6 years. If symptoms persist, have not improved, or have worsened after 3 days, consult a doctor or health care professional. Important information about some of the ingredients of this medicine: This medicine contains sucrose (1.44g per lozenge) and glucose (0.98g per lozenge). This should be taken into account in patients with diabetes mellitus. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltose insufficiency should not take this medicine. This medicine contains only very low levels of gluten (from wheat starch). It is regarded as ‘gluten-free’ and is very unlikely to cause problems if you have coeliac disease. One lozenge contains no more than 19.52 micrograms of gluten. If you have wheat allergy (different from coeliac disease) you should not take this medicine. This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’. This medicine contains fragrance with Citral, d-Limonene, Geraniol and Linalool. Citral, d-Limonene, Geraniol and Linalool may cause allergic reactions. This medicine contains Sulphites – Sulphur Dioxide (E220) (present in liquid glucose) which may rarely cause severe hypersensitivity reactions and bronchospasm.4.5 Interaction with other medicinal products and other forms of interaction No clinically significant interactions are known.4.6 Fertility, pregnancy and lactation Pregnancy There are no or limited amount of data from the use of amylmetacresol and 2,4-dichlorbenzyl alcohol. As with all medicines care should be taken when using this product in pregnancy and medical advice sought if necessary. Breast-feeding It is unknown whether 2,4-dichlorobenzyl alcohol, amylmetacresol or metabolites are excreted in human milk. A risk to the newborns / infants cannot be excluded. Fertility No data are available regarding the effects on fertility.4.7 Effects on ability to drive and use machines No or negligible influence on the ability to drive and use machines.4.8 Undesirable effects The list of the following adverse effects relates to those experienced with 2,4-dichlorobenzyl alcohol and amylmetacresol at OTC doses, in short term use. Adverse events which have been associated with 2,4-dichlorobenzyl alcohol and amylmetacresol are given below, tabulated by system organ class and frequency. Frequencies are defined as: Very common (≥1/10); Common (≥1/100 and <1/10); Uncommon (≥1/1000 and <1/100); Rare (≥1/10,000 and <1/1000); Very rare (<1/10,000); Not known (cannot be estimated from the available data). Within each frequency grouping, adverse events are presented in order of decreasing seriousness.
| System Organ Class | Frequency | Adverse Events |
| Immune System Disorders | Not known | Hypersensitivity ab1 |
| Gastrointestinal Disorders | Not known | Glossodynia ab, oral discomfort ab |
a 2,4-dichlorobenzyl alcohol b amylmetacresol 1 Hypersensitivity reactions may include rash, urticaria and angioedema, which may include swelling of the face, neck, throat or tongue that could affect breathing. Reporting of Suspected Adverse Reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
- It allows continued monitoring of the benefit/risk balance of the medicinal product.
- Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.4.9 Overdose Overdosage should not present a problem other than gastrointestinal discomfort.
Treatment should be symptomatic.5. Pharmacological properties 5.1 Pharmacodynamic properties Pharmacotherapeutic group: Throat Preparations; Antiseptics ; ATC Code: R02AA03 Dichlorobenzyl alcohol.2,4-dichlorobenzyl alcohol and amylmetacresol are antiseptics and possess antibacterial (bactericidal and bacteriostatic), antifungal and antiviral properties as demonstrated in vitro,
When the two active agents are combined, a synergistic antibacterial action is observed leading to a reduced combined dose. In-vitro studies demonstrated killing effects against some sore throat causing organisms such as Streptococcus pyogenes, Staphylococcus aureus, Haemophilus influenza and Moraxella catarrhalis, at 1 minute contact time.
An overall reduction in the oral bacterial load was also seen in one in-vivo study. In-vitro antiviral action against enveloped viruses including influenza A virus, para-influenza virus, respiratory syncytial virus, cytomegalovirus and coronavirus has also been observed for both AMC and DCBA as well as the combination of the two after 1-2 minutes contact.
- In clinical studies, there was evidence that Strepsils lozenges led to reduction of throat soreness, and provided relief from pain and difficulty in swallowing, with onset of activity in 5 minutes and lasting for up to 2 hours.
- Significantly more relief than non-medicated lozenge was also demonstrated for up to 3 days treatment.
In one study, Strepsils lozenges have also been shown to significantly decrease post-operative throat soreness and hoarseness 20 minutes and 24 hours after intubation. A study in children (6-16 years) with acute and recurring chronic sore throat demonstrated a reduction in subjective and objective signs of sore throat over 3 days of treatment with Strepsils lozenges.
Strepsils Honey & Lemon lozenges contain flavours and honey whilst the base has a demulcent action providing throat soothing.5.2 Pharmacokinetic properties None available.5.3 Preclinical safety data None available.6. Pharmaceutical particulars 6.1 List of excipients Honey, tartaric acid, peppermint oil (containing d-Limonene), terpeneless lemon oil (containing Fragrance containing allergens – Citral, d-Limonene, Geraniol and Linalool), quinoline yellow, liquid sucrose, liquid glucose (containing sulphites – Sulphur Dioxide (E220) and wheat starch (containing gluten)), potable water.6.2 Incompatibilities Not applicable.6.3 Shelf life 36 months for lozenges packed in blister strips within a carton.36 months for lozenges packed in polypropylene tube, with an in use shelf-life of ‘use within 3 months of opening’.18 months for blister packs attached to a stencilled card.6.4 Special precautions for storage Do not store above 25°C.6.5 Nature and contents of container A blister push through pack consisting of hard temper aluminium foil heat-sealed to a PVC/PVDC blister.
The tray contains an appropriate number of lozenges to give pack sizes of 4, 6, 8, 10, 12, 16, 20, 24, 32, 36 and 48 lozenges in cardboard cartons or a flow wrap outer composed of PET/aluminium foil/polyethylene Sample packs consisting of two, four or six individual lozenge blister strips attached to a card.
- A blister push-through pack consisting of hard temper aluminium foil heat-sealed to a PVC/PVDC blister.
- The tray contains an appropriate number of lozenges to give a pack size of 8 lozenges in a wrap around cardboard carton with tamper-evident seal.
- An injection moulded white pigmented polypropylene tube with an injection moulded white polyethylene cap (containing white silica gel that is sealed with a white cardboard disc).
The tube contains 10 lozenges.20 lozenges consisting of a bundled pack of 2 tubes of 10 lozenges each. Not all pack sizes may be marketed.6.6 Special precautions for disposal and other handling Not applicable.7. Marketing authorisation holder Reckitt Benckiser Healthcare (UK) Ltd Slough SL1 3UH 8.
What are the side effects of Strepsils?
Like all medicines, Strepsils Lozenges for Adults and Children Over Six can cause side effects, although not everybody gets them. Side effects may include rash, stomach pain, feeling sick, oral discomfort, allergic reaction.
Can I take Strepsils with paracetamol?
Can I use Strepsils extra triple action lozenges with other medicines? – Strepsils extra lozenges are not known to affect any other medicines. However, if you are already using any other medicines you should get advice from your pharmacist before taking this one as well.
Does Strepsils have antibiotic?
Introduction – On average, an adult will suffer from a sore throat 2–3 times per year, with children being prone to more frequent episodes of sore throat than adults ( 1 ), because of their immunological naivety. Acute sore throat is one of the most common complaints associated with upper respiratory tract infections (URTIs) that result in presentation at general practice surgeries ( 2 ) or local pharmacy stores for treatment.
- Approximately a quarter of the population in England and Wales will consult their physician each year because of a respiratory tract infection ( 3 ).
- Respiratory tract infections that include URTIs and lower respiratory tract infections are the reason for 60% of all antibiotic prescribing in general practice, resulting in significant costs to the healthcare system ( 4 ).
Over the years, our understanding of the aetiology of sore throat has diversified beyond bacterial causes. Contrary to commonly held historical beliefs, bacterial infections are not the most common cause of sore throats. The most common bacterial cause, group A β‐haemolytic streptococcus ( Streptococcus pyogenes ), only account for approximately 20% of all sore throats in adults and young children ( 5 ).
- In fact, up to 80% of sore throats in adults are caused by viruses ( 5, 6 ), such as influenza A, respiratory syncytial virus, severe acute respiratory syndrome coronavirus and rhinovirus ( 7 ).
- Thus, antibiotics are generally not suitable for the treatment of acute sore throats ( 8 ).
- Many country guidelines, including the National Institute for Health and Clinical Excellence guidelines in the UK, have advised against the use of antibiotics for minor ailments including acute sore throat, for fear of antibiotic resistance and unnecessary exposure to potential adverse effects ( 4 ).
A no or delayed antibiotic prescribing strategy was recommended for adults and children, except for those patients who are at high risk of associated complications, such as quinsy ( 4 ). Therefore, the availability of over‐the‐counter (OTC) treatments is becoming increasingly important and plays an important role in the self‐management of acute sore throat, especially the availability of clinically efficacious, well‐tolerated, fast‐ and long‐acting products.
There are many OTC treatments available for the self‐management of sore throats, including throat lozenges and other topical treatments, such as pastilles, sprays and gargles, but there is a lack of recent evidence in the literature to support the efficacy of the latter three product types. Although medicated topical treatments act to relieve sore throats primarily by delivering the active ingredients directly to the areas affected, gargles are only able to deliver the active ingredients to the anterior oral cavity and not the palatine tonsils or the pharynx ( 9 ).
Conversely, medicated throat lozenges have the added advantage over sprays and gargles of being slow‐releasing ( 10 ), ensuring continuous delivery of the active ingredients to all affected areas of the throat and over a prolonged period of time ( 11 ).
- Strepsils ® (Reckitt Benckiser Healthcare International, Hull, UK) lozenges are medicated lozenges that contain the antibacterial ( 12, 13, 14 ) and antiviral ( 7 ) ingredients amylmetacresol (AMC; 0.6 mg) and 2,4‐dichlorobenzyl alcohol (DCBA; 1.2 mg).
- From here on in this study, Strepsils lozenges will be referred to by its generic name ‘AMC/DCBA throat lozenges’.
Several studies exist to support the efficacy and safety of AMC/DCBA throat lozenges in the relief of acute sore throat pain ( 15, 16, 17, 18, 19 ). However, many of these studies were performed on small number of patient and were insufficiently powered to draw strong statistical conclusions.
In addition, to date, no studies have examined the effect of throat lozenges on everyday activities impaired by sore throat‐related pain/symptoms. Therefore, this study was conducted in a larger group of patients to further examine the analgesic and functional benefits of AMC/DCBA throat lozenges vs.
non‐medicated placebo lozenges in patients with acute sore throat over a period of 3 days.
Why is my sore throat worse at night?
Treatment – The following strategies may help reduce snoring and OSA:
avoiding drinking alcohol before bedtimeavoiding nonessential medicines that can increase sleepinessavoiding sleeping on the backreaching or maintaining a moderate weight
If the above strategies do not alleviate OSA, a person should see their doctor. The doctor may recommend one or more of the following treatments:
Continuous positive airway pressure (CPAP) device: A machine that pumps pressurized air through a face mask and into a person’s airways while they sleep. This helps keep the airways open, thereby reducing episodes of sleep apnea. Dental devices: Some people may benefit from a dental device that brings the bottom jaw forward. This may help keep the airways open. Surgery: If other treatment options are ineffective, a doctor may recommend surgery to remove excess tissue from the back of the throat or to remove or bypass airway blockages.
Allergies can cause nasal congestion and postnasal drip, This is where mucus drains from the nose and into the throat. Excess mucus in the throat can lead to itching, irritation, and soreness. Postnasal drip typically increases when a person is lying down.
feathers in pillowsdust and dander in mattressespollen from plants or trees near an open window
How long can COVID sore throat last?
How long does a COVID-19 sore throat last? Most symptoms of COVID-19 last anywhere from several days to 2 weeks. But this can vary from person to person. COVID sore throat usually starts feeling better after a week, though it may take a little longer to completely go away.
Do Strepsils get rid of strep throat?
The lowdown – Many people with sore throats turn to lozenges. However, they only soothe the throat and reduce the pain and soreness. Lozenges do not treat the actual cause of sore throat, which in the case of strep throat is group A streptococci. Considering lozenges as treatment for sore throat could be dangerous if you suffer from strep throat, since leaving it untreated could cause life-threatening complications.
